Who owns NRX PHARMACEUTICALS INC?
- CUSIP Number: 629444209
Tip: Access positions for across all investors
Analyze quarterly positions in Nrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Nrx Pharmaceuticals stock
Who bought or sold NRX PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 240k | $586k | 100% | Jun 2024 |
|
AdvisorShares Investments | 108k | $279k | 100% | Jun 2024 |
|
Geode Capital Management | 66k | $160k | 100% | Jun 2024 |
|
Susquehanna International | 61k | $148k | 100% | Jun 2024 |
|
BlackRock | 29k | $71k | 100% | Jun 2024 |
|
Citadel Advisors | 23k | $57k | 100% | Jun 2024 |
|
Virtu Financial | 17k | $42k | 100% | Jun 2024 |
|
State Street Corporation | 17k | $41k | 100% | Jun 2024 |
|
One Wealth Management Investment & Advisory Services | 15k | $37k | 100% | Jun 2024 |
|
Morgan Stanley | 4.4k | $11k | 100% | Jun 2024 |
|
Royal Bank of Canada | 4.0k | $0 | 100% | Jun 2024 |
|
Tower Research Capital | 3.3k | $8.1k | 100% | Jun 2024 |
|
Bank of America Corporation | 3.3k | $8.0k | 100% | Jun 2024 |
|
Wells Fargo & Company | 1.5k | $3.7k | 100% | Jun 2024 |
|
Goss Wealth Management | 583.00 | $1.4k | 100% | Jun 2024 |
|
Qube Research & Technologies | 117.00 | $285.000300 | 100% | Jun 2024 |
|
Harbour Investments | 47.00 | $114.999600 | 100% | Jun 2024 |
|
Jpmorgan Chase & Co | 34.00 | $83.000800 | 100% | Jun 2024 |
|
Larson Financial Group | 22.00 | $53.999000 | 100% | Jun 2024 |
|